Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) was the target of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 6,550,000 shares, a growth of 9.3% from the October 31st total of 5,990,000 shares. Based on an average daily volume of 1,600,000 shares, the days-to-cover ratio is currently 4.1 days.
ACHC has been the topic of a number of research analyst reports. KeyCorp began coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They set a "sector weight" rating on the stock. Royal Bank of Canada reduced their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating for the company in a report on Monday, November 18th. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Barclays cut their target price on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a research report on Friday, November 22nd. Finally, StockNews.com lowered Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Friday, November 22nd. One analyst has rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $79.67.
Get Our Latest Research Report on Acadia Healthcare
A number of institutional investors have recently added to or reduced their stakes in ACHC. Harbor Capital Advisors Inc. purchased a new stake in shares of Acadia Healthcare in the second quarter worth about $800,000. TCW Group Inc. raised its position in shares of Acadia Healthcare by 63.8% in the second quarter. TCW Group Inc. now owns 62,888 shares of the company's stock worth $4,247,000 after buying an additional 24,487 shares in the last quarter. SG Americas Securities LLC boosted its stake in Acadia Healthcare by 435.6% during the second quarter. SG Americas Securities LLC now owns 18,227 shares of the company's stock valued at $1,231,000 after buying an additional 14,824 shares during the period. Principal Financial Group Inc. grew its position in Acadia Healthcare by 19.4% during the second quarter. Principal Financial Group Inc. now owns 643,521 shares of the company's stock worth $43,463,000 after buying an additional 104,359 shares in the last quarter. Finally, LMR Partners LLP bought a new position in Acadia Healthcare in the 3rd quarter worth about $1,616,000.
ACHC opened at $40.63 on Monday. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The company's 50-day moving average price is $50.46 and its two-hundred day moving average price is $63.52. The stock has a market cap of $3.77 billion, a price-to-earnings ratio of 13.32, a PEG ratio of 1.80 and a beta of 1.33.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. During the same quarter last year, the business earned $0.91 earnings per share. The company's quarterly revenue was up 8.7% on a year-over-year basis. As a group, equities analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current year.
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.